A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI
Neurobiology of Disease · 2024
DOI: 10.1016/j.nbd.2024.106709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Bram Callewaert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular and Vascular Biology (CMVB), Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium; Biomedical MRI unit, Depart…. Hauptthemen laut MEDLINE: Cerebrovascular Circulation, Blood-Brain Barrier. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission, KU Leuven.
Abstract (Originalsprache)
Endothelial dysfunction is considered a key element in the early pathogenesis of neurodegenerative disorders. Dysfunction of the cerebral endothelial cells can result in dysregulation of cerebral perfusion and disruption of the Blood Brain Barrier (BBB), leading to brain damage, neurodegeneration and cognitive decline. It has been shown that the presence of modifiable risk factors exacerbates endothelial dysfunction. This study primarily aimed to identify which among various perfusion MRI methodologies could be effectively utilized to non-invasively identify early pathological alterations as a result of endothelial dysfunction. We compared these perfusion MRI measurements to invasive immunohistochemistry to detect early pathological alterations in the cerebral vasculature of a rat model of multiple cardiovascular co-morbidities (the ZSF1 Obese rat) at several stages of the cerebrovascular pathology. We observed cerebral hyperperfusion, expressed by increased Cerebral Blood Flow (CBF) and increased BBB permeability in the ZSF1 Obese rats, at an early stage of disease development. The increase in CBF observed with Arterial Spin Labeling (ASL) was lost during later stages of disease progression. These findings are in line with recent clinical findings in early stages of Alzheimer's disease (AD), that also show early increases in CBF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Molecular and Vascular Biology (CMVB), Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium; Biomedical MRI unit, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.
- Biomedical MRI unit, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.
- Center for Molecular and Vascular Biology (CMVB), Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.
- Center for Molecular and Vascular Biology (CMVB), Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium; School for Cardiovascular Diseases (CARIM), Department of Cardiology, Maastricht University, 6200…
Förderung
- European Commission
- KU Leuven
Zitieren
APA
Callewaert, B., Gsell, W., Lox, M., Himmelreich, U., & Jones, E. A. V. (2024). A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106709
Vancouver
Callewaert B, Gsell W, Lox M, Himmelreich U, Jones EAV. A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106709
BibTeX
@article{Callewaert2024,
author = {Callewaert, Bram and Gsell, Willy and Lox, Marleen and Himmelreich, Uwe and Jones, Elizabeth A V},
title = {A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI},
journal = {Neurobiology of Disease},
year = {2024},
doi = {10.1016/j.nbd.2024.106709}
}
EUVIMED